Search
Now showing items 1-10 of 48
Development of cancer risk prediction models into tools for use in clinical settings
(2018-10)
Meeting abstract P19.07C from 50th European-Society-of-Human-Genetics (ESHG) Conference
Cochrane systematic review of diagnostic accuracy of dermoscopy in comparison to visual inspection for the diagnosis of melanoma
(2018-07)
Meeting abstract DS02 from British Association of Dermatologists 98th Annual Meeting, Edinburgh, U.K., 3–5 July 2018
"I Thought I Was Controlling a Temporary Problem'': Exploring Patient Experience Along the Pathway to Diagnosis for Oesophageal and Gastric Cancer
(2018-03-15)
Abstract from Qualitative Health Research Conference, 2017
Erratum: The Improving Rural Cancer Outcomes Trial: a cluster-randomised controlled trial of a complex intervention to reduce time to diagnosis in rural cancer patients in Western Australia
(2018-03-20)
Correction to: British Journal of Cancer (2017) 117, 1459–1469; doi:https://doi.org/10.1038/bjc.2017.310; published online 19 September 2017
Symptom awareness measures for breast and cervical cancer in sub-Saharan Africa: A scoping review
(AOSIS, 2019-06-26)
Background: In sub-Saharan Africa (SSA), breast cancer is the most commonly diagnosed cancer among women, while cervical cancer remains the leading cause of cancer death. Women often fail to recognise or misinterpret ...
Primary care genomic research: One eye on the future
(SAGE Publications, 2020-11-25)
The exceptional advances in genomic medicine in the last two decades, since the sequencing of the human genome, have already had a major impact on healthcare in the UK. Until recently this was predominantly in secondary ...
Understanding missed opportunities for more timely diagnosis of brain cancer – what can we learn from the BRACED qualitative interview study with adult glioma patients?
(2018-01-31)
BACKGROUND
BRACED (The BRAin Cancer Early Detection study) is a qualitative study of patient perspectives on factors affecting timely diagnosis of primary brain tumours. Patient, doctor and health-care system-related ...
RESULTS FROM THE BARRETT'S OESOPHAGUS TRIAL 3 (BEST3): A RANDOMISED CONTROLLED TRIAL COMPARING THE CYTOSPONGE (TM)-FF3 TEST WITH USUAL CARE TO IDENTIFY OESOPHAGEAL PRE-CANCER IN PRIMARY CARE PATIENTS WITH CHRONIC GASTROESOPHAGEAL REFLUX
(2020-05)
Meeting Abstract 634 from Crohn's and Colitis Congress, Austin, TX, JAN 23-25, 2020
